1. Dasgupta PK,
Liu Y, Dyke JV.
Iodine nutrition:
iodine content of
iodized salt in the
United States.
Environ Sci
Technol. 2008 Feb
15;42(4):1315-23.
2. Dasgupta PK,
Liu Y, Dyke JV.
Iodine nutrition:
iodine content of
iodized salt in the
United States.
Environ Sci
Technol. 2008 Feb
15;42(4):1315-23.
3. Gunton JE,
Hams G, Fiegert M,
McElduff A. Iodine
deficiency in
ambulatory
participants at a
Sydney teaching
hospital: is
Australia truly
iodine replete? Med
J Aust. 1999 Nov
1;171(9):467-70.
4. Hoption Cann
SA. Hypothesis:
dietary iodine
intake in the
etiology of
cardiovascular
disease. J Am Coll
Nutr. 2006
Feb;25(1):1-11.
5. Kapil U,
Sharma TD, Singh P,
Dwivedi SN, Kaur S.
Thirty years of a
ban on the sale of
noniodized salt:
impact on iodine
nutrition in
children in
Himachal Pradesh,
India. Food Nutr
Bull. 2005
Sep;26(3):255-8.
6. Dunn JT.
Seven deadly sins
in confronting
endemic iodine
deficiency, and how
to avoid them. J
Clin Endocrinol
Metab. 1996
Apr;81(4):1332-5.
7. McClure RD.
Goiter prophylaxis
with iodized salt.
Science. 1935 Oct
18;82(2129):370–1.
8. Darcan S,
Goksen D.
Consequences of
iodine deficiency
and preventive
measures. Pediatr
Endocrinol Rev.
2003 Dec;1 Suppl
2:162-8; discussion
68-9.
9. Szybinski Z,
Jarosz M,
Hubalewska-Dydejczyk
A, et al.
Iodine-deficiency
prophylaxis and the
restriction of salt
consumption - a
21st century
challenge.
Endokrynol Pol.
2010
Jan-Feb;61(1):135-40.
10. Zimmermann
MB. Iodine
deficiency. Endocr
Rev. 2009
Jun;30(4):376-408.
11. Triggiani V,
Tafaro E, Giagulli
VA, et al. Role of
iodine, selenium
and other
micronutrients in
thyroid function
and disorders.
Endocr Metab Immune
Disord Drug
Targets. 2009
Sep;9(3):277-94.
12.
Bibbins-Domingo K,
Chertow GM, Coxson
PG, et al.
Projected effect of
dietary salt
reductions on
future
cardiovascular
disease. N Engl J
Med. 2010 Feb
18;362(7):590-9.
13. Titze J,
Ritz E. Salt and
its effect on blood
pressure and target
organ damage: new
pieces in an old
puzzle. J Nephrol.
2009
Mar-Apr;22(2):177-89.
14. Caldwell KL,
Jones R, Hollowell
JG. Urinary iodine
concentration:
United States
National Health And
Nutrition
Examination Survey
2001-2002. Thyroid.
2005
Jul;15(7):692-9.
15. Wang GY,
Zhou RH, Wang Z,
Shi L, Sun M.
Effects of storage
and cooking on the
iodine content in
iodized salt and
study on monitoring
iodine content in
iodized salt.
Biomed Environ Sci.
1999
Mar;12(1):1-9.
16.
Krajcovicova-Kudlackova
M, Buckova K,
Klimes I, Sebokova
E. Iodine
deficiency in
vegetarians and
vegans. Ann Nutr
Metab.
2003;47(5):183-5.
17. Smyth PP,
Duntas LH. Iodine
uptake and loss-can
frequent strenuous
exercise induce
iodine deficiency?
Horm Metab Res.
2005
Sep;37(9):555-8.
18. Patrick L.
Iodine: deficiency
and therapeutic
considerations.
Altern Med Rev.
2008
Jun;13(2):116-27.
19.
Baier-Anderson C,
Blount BC, Lakind
JS, Naiman DQ,
Wilbur SB, Tan S.
Estimates of
exposures to
perchlorate from
consumption of
human milk, dairy
milk, and water,
and comparison to
current reference
dose. J Toxicol
Environ Health A.
2006
Feb;69(3-4):319-30.
20. Sanchez CA,
Krieger RI,
Khandaker N, Moore
RC, Holts KC,
Neidel LL.
Accumulation and
perchlorate
exposure potential
of lettuce produced
in the Lower
Colorado River
region. J Agric
Food Chem. 2005 Jun
29;53(13):5479-86.
21. Snyder SA,
Pleus RC,
Vanderford BJ,
Holady JC.
Perchlorate and
chlorate in dietary
supplements and
flavor enhancing
ingredients. Anal
Chim Acta. 2006 May
10;567(1):26-32.
22. Greer MA,
Goodman G, Pleus
RC, Greer SE.
Health effects
assessment for
environmental
perchlorate
contamination: the
dose response for
inhibition of
thyroidal
radioiodine uptake
in humans. Environ
Health Perspect.
2002
Sep;110(9):927-37.
23. Available
at:
http://lpi.oregonstate.edu/infocenter/minerals/iodine/.
Accessed July 18,
2011.
24. Available
at:
http://emedicine.medscape.com/article/122714-overview.
Accessed July 18,
2011.
25. Cann SA, van
Netten JP, van
Netten C.
Hypothesis: iodine,
selenium and the
development of
breast cancer.
Cancer Causes
Control. 2000
Feb;11(2):121-7.
26. Nagataki S,
Shizume K, Nakao K.
Thyroid function in
chronic excess
iodide ingestion:
comparison of
thyroidal absolute
iodine uptake and
degradation of
thyroxine in
euthyroid Japanese
subjects. J Clin
Endocrinol Metab.
1967
May;27(5):638-47.
27. Canturk Z,
Cetinarslan B,
Tarkun I, Canturk
NZ, Ozden M. Lipid
profile and
lipoprotein (a) as
a risk factor for
cardiovascular
disease in women
with subclinical
hypothyroidism.
Endocr Res. 2003
Aug;29(3):307-16.
28. Iqbal A,
Jorde R, Figenschau
Y. Serum lipid
levels in relation
to serum
thyroid-stimulating
hormone and the
effect of thyroxine
treatment on serum
lipid levels in
subjects with
subclinical
hypothyroidism: the
Tromso Study. J
Intern Med. 2006
Jul;260(1):53-61.
29. Fazio S,
Palmieri EA,
Lombardi G, Biondi
B. Effects of
thyroid hormone on
the cardiovascular
system. Recent Prog
Horm Res.
2004;59:31-50.
30. Canaris GJ,
Steiner JF, Ridgway
EC. Do traditional
symptoms of
hypothyroidism
correlate with
biochemical
disease? J Gen
Intern Med. 1997
Sep;12(9):544-50.
31. Wartofsky L.
Management of
subclinical
hyperthyroidism. J
Clin Endocrinol
Metab. 2011
Jan;96(1):59-61.
32. Kramer CK,
Von Muhlen D,
Kritz-Silverstein
D, Barrett-Connor
E. Treated
hypothyroidism,
depressed mood, and
cognitive function
in old age: the
Rancho Bernardo
Study. Eur J
Endocrinol. 2009
Dec;
161(6):917-21
33. Zimmermann
MB. Iodine
deficiency in
pregnancy and the
effects of maternal
iodine
supplementation on
the offspring: a
review. Am J Clin
Nutr. 2009
Feb;89(2):668S-72S.
34. Verheesen
RH, Schweitzer CM.
Iodine deficiency,
more than cretinism
and goiter. Med
Hypotheses. 2008
Nov;71(5):645-8.
35. Laurberg P,
Nohr SB, Pedersen
KM, et al. Thyroid
disorders in mild
iodine deficiency.
Thyroid. 2000
Nov;10(11):951-63.
36. Bretthauer
EW, Mullen AL,
Moghissi AA. Milk
transfer
comparisons of
different chemical
forms of
radioiodine. Health
Phys. 1972
Mar;22(3):257-60.
37. Spitzweg C,
Harrington KJ,
Pinke LA, Vile JG,
Morris JC. Clinical
review 132: the
sodium iodide
symporter and its
potential role in
cancer therapy. J
Clin Endocrinol
Metab 2001
Jul;86(7):3327-35.
38. Kilbane MT,
Ajjan RA, Weetman
AP, et al. Tissue
iodine content and
serum-mediated 125I
uptake-blocking
activity in breast
cancer. J Clin
Endocrinol Metab.
2000
Mar;85(3):1245-50.
39. Topper YJ,
Freeman CS.
Multiple hormone
interactions in the
developmental
biology of the
mammary gland.
Physiol Rev 1980
Oct;60(4):1049-106
40. Eskin BA.
Iodine and mammary
cancer. Adv Exp Med
Biol.
1977;91:293-304.
41. Smyth PP.
Role of iodine in
antioxidant defence
in thyroid and
breast disease.
Biofactors.
2003;19(3-4):121-30.
42. Venturi S,
Donati FM, Venturi
A, Venturi M,
Grossi L, Guidi A.
Role of iodine in
evolution and
carcinogenesis of
thyroid, breast and
stomach. Adv Clin
Path. 2000
Jan;4(1):11-7.
43. Venturi S.
Is there a role for
iodine in breast
diseases? Breast.
2001
Oct;10(5):379-82.
44. Stadel BV.
Dietary iodine and
risk of breast,
endometrial, and
ovarian cancer.
Lancet. 1976 Apr
24;1(7965):890-1.
45. Many MC,
Papadopolos C,
Martin I, et al.
Iodine induced cell
damage in mouse
hyperplastic
thyroid is
associated with
lipid peroxidation.
In: Gordon A, Gross
J, Hennemann G,
eds. Progress in
Thyroid Research.
New York, NY:
Routledge;
1991:213-5.
46. Nolan LA,
Windle RJ, Wood SA,
et al. Chronic
iodine deprivation
attenuates
stress-induced and
diurnal variation
in corticosterone
secretion in female
Wistar rats. J
Neuroendocrinol.
2000
Dec;12(12):1149-59.
47. Stolc V.
Stimulation of
iodoproteins and
thyroxine formation
in human leukocytes
by phagocytosis.
Biochem Biophys Res
Commun. 1971 Oct
1;45(1):159-66.
48. Cohen M,
Klein E, Kuten A,
Fried G, Zinder O,
Pollack S.
Increased emotional
distress in
daughters of breast
cancer patients is
associated with
decreased natural
cytotoxic activity,
elevated levels of
stress hormones and
decreased secretion
of Th1 cytokines.
Int J Cancer. 2002
Jul
20;100(3):347-54.
49. Inaudi P,
Bernabei A, Gioffre
W, et al. Plasma
and cyst fluid
levels of delta 5
and delta 4 steroid
hormones in women
with gross cystic
breast disease.
Clin Endocrinol
(Oxf). 1987
Dec;27(6):643-8.
50. James GD,
Gastrich HJ,
Valdimarsdottir HB,
Bovbjerg DH. The
rate of urinary
cortisol excretion
at work is
persistently
elevated in women
at familial risk
for breast cancer.
Am J Hum Biol. 2008
Jul-Aug;20(4):478-80.
51. Thornton LM,
Andersen BL, Carson
WE, 3rd. Immune,
endocrine, and
behavioral
precursors to
breast cancer
recurrence: a
case-control
analysis. Cancer
Immunol Immunother.
2008
Oct;57(10):1471-81.
52. Smyth PP.
The thyroid, iodine
and breast cancer.
Breast Cancer Res.
2003;5(5):235-8.
53. Smyth PP.
Thyroid disease and
breast cancer. J
Endocrinol Invest.
1993
May;16(5):396-401.
54. Aceves C,
Anguiano B, Delgado
G. Is iodine a
gatekeeper of the
integrity of the
mammary gland? J
Mammary Gland Biol
Neoplasia. 2005
Apr;10(2):189-96.
55. Ziegler RG,
Hoover RN, Pike MC,
et al. Migration
patterns and breast
cancer risk in
Asian-American
women. J Natl
Cancer Inst. 1993
Nov
17;85(22):1819-27.
56. Garcia-Solis
P, Alfaro Y,
Anguiano B, et al.
Inhibition of
N-methyl-N-nitrosourea-induced
mammary
carcinogenesis by
molecular iodine
(I2) but not by
iodide (I-)
treatment Evidence
that I2 prevents
cancer promotion.
Mol Cell
Endocrinol. 2005
May
31;236(1-2):49-57.
57. Funahashi H,
Imai T, Tanaka Y,
et al. Suppressive
effect of iodine on
DMBA-induced breast
tumor growth in the
rat. J Surg Oncol.
1996
Mar;61(3):209-13.
58. Shrivastava
A, Tiwari M, Sinha
RA, et al.
Molecular iodine
induces
caspase-independent
apoptosis in human
breast carcinoma
cells involving the
mitochondria-mediated
pathway. J Biol
Chem. 2006 Jul
14;281(28):19762-71.
59. Goehring C,
Morabia A.
Epidemiology of
benign breast
disease, with
special attention
to histologic
types. Epidemiol
Rev.
1997;19(2):310-27.
60. Krouse TB,
Eskin BA, Mobini J.
Age-related changes
resembling
fibrocystic disease
in iodine-blocked
rat breasts. Arch
Pathol Lab Med.
1979
Nov;103(12):631-4.
61. Eskin BA,
Grotkowski CE,
Connolly CP, Ghent
WR. Different
tissue responses
for iodine and
iodide in rat
thyroid and mammary
glands. Biol Trace
Elem Res. 1995
Jul;49(1):9-19.
62. Ghent WR,
Eskin BA, Low DA,
Hill LP. Iodine
replacement in
fibrocystic disease
of the breast. Can
J Surg. 1993
Oct;36(5):453-60.
63. Kahaly GJ.
Cardiovascular and
atherogenic aspects
of subclinical
hypothyroidism.
Thyroid. 2000
Aug;10(8):665-79.
64. Park YJ, Lee
YJ, Choi SI, Chun
EJ, Jang HC, Chang
HJ. Impact of
subclinical
hypothyroidism on
the coronary artery
disease in
apparently healthy
subjects. Eur J
Endocrinol. 2011
Jul;165(1):115-21.
65. Haentjens P,
Van Meerhaeghe A,
Poppe K, Velkeniers
B. Subclinical
thyroid dysfunction
and mortality: An
estimate of
relative and
absolute excess
all-cause mortality
based on
time-to-event data
from cohort
studies. Eur J
Endocrinol. 2008
Sep;159(3):329-41.
66. Rizos CV,
Elisaf MS,
Liberopoulos EN.
Effects of thyroid
dysfunction on
lipid profile. Open
Cardiovasc Med J.
2011;5:76-84.
67. Molnar I,
Magyari M, Stief L.
Iodine deficiency
in cardiovascular
diseases. Orv
Hetil. 1998 Aug
30;139(35):2071-3.
68. Jung CH,
Sung KC, Shin HS,
et al. Thyroid
dysfunction and
their relation to
cardiovascular risk
factors such as
lipid profile,
hsCRP, and waist
hip ratio in Korea.
Korean J Intern
Med. 2003
Sep;18(3):146-53.
69. Mariotti S,
Cambuli VM.
Cardiovascular risk
in elderly
hypothyroid
patients. Thyroid.
2007
Nov;17(11):1067-73.
70. Venturi S,
Venturi M. Iodine
in evolution of
salivary glands and
in oral health.
Nutr Health.
2009;20(2):119-34.
71. Abnet CC,
Fan JH, Kamangar F,
et al.
Self-reported
goiter is
associated with a
significantly
increased risk of
gastric noncardia
adenocarcinoma in a
large
population-based
Chinese cohort. Int
J Cancer. 2006 Sep
15;119(6):1508-10.
72. Behrouzian
R, Aghdami N.
Urinary
iodine/creatinine
ratio in patients
with stomach cancer
in Urmia, Islamic
Republic of Iran.
East Mediterr
Health J. 2004
Nov;10(6):921-4.
73. Gulaboglu M,
Yildiz L, Celebi F,
Gul M, Peker K.
Comparison of
iodine contents in
gastric cancer and
surrounding normal
tissues. Clin Chem
Lab Med.
2005;43(6):581-4.
74. Golkowski F,
Szybinski Z,
Rachtan J, et al.
Iodine
prophylaxis—the
protective factor
against stomach
cancer in iodine
deficient areas.
Eur J Nutr. 2007
Aug;46(5):251-6.
75. Kupper FC,
Carpenter LJ,
McFiggans GB, et
al. Iodide
accumulation
provides kelp with
an inorganic
antioxidant
impacting
atmospheric
chemistry. Proc
Natl Acad Sci U S
A. 2008 May
13;105(19):6954-8.
|